Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
AssigneeVecta, Ltd.
InventorsMichal Y. Chowers, Yehuda Chowers
Life of this patent
Estimating the term…
Abstract
The invention relates to pharmaceutical compositions and methods for treating and/or preventing Helicobacter pylori-associated disorders, particularly disorders of the gastrointestinal tract. The pharmaceutical compositions comprise as active ingredient a therapeutically effective amount of a compound which inhibits the growth-enhancing effect of gastrin on H. pylori. The active ingredient may specifically be a compound which is capable of inhibiting gastrin uptake by H. pylori, and/or which is an antagonist of the human or H. pylori gastrin receptor.
Claims26
A pharmaceutical composition for the treatment and/or prevention of H. pylori-associated disorders comprising as active ingredient a therapeutically effective amount of a compound which inhibits the growth-enhancing effect of gastrin on H. pylori, optionally further comprising pharmaceutically acceptable carriers, adjuvants or diluents.
A method according to claim 13 or 14, wherein said compound is capable of inhibiting gastrin uptake by H. pylori.
Use of a compound which inhibits the growth-enhancing effect of gastrin on H. pylori in the preparation of a pharmaceutical composition for the treatment of H. pylori-associated disorders.
Dependencies are inferred from the claim text.